Oral Rabies Vaccine Deployed by Air to Vaccinate Wildlife in Vermont
On May 5, 2025, the U.S. Department of Agriculture (USDA) Wildlife Services (WS), in coordination with the Vermont Department of Health, conducted a spring rabies vaccine bait drop to help combat rising rabies rates among wildlife in Vermont.1 According to Natalie Kwit, state public health veterinarian with the Vermont Health Department, rabies cases have been […]
ACIP Considers Changes to HPV Vaccine Recommendations
The U.S. Centers for Disease Control and Prevention’s (CDC) current universal use recommendation for the HPV (human papillomavirus) vaccine is two doses given to adolescent by ages 11-12 and three doses if the series is started on or after age 15. The vaccine can be given to children as young as age nine, but that […]
Autism Epidemic ‘Unprecedented in Human History,’ Now Reaches 1 in 31 Kids in America
On Apr. 15, 2025, the U.S. Centers for Disease Control and Prevention (CDC) published an analysis in its epidemiological digest Morbidity and Mortality Weekly Report (MMWR) which found the prevalence of autism spectrum disorder (ASD) among children eight years old in the United States to be 1 in 31 (3.2 percent).1 2 3 4 5 […]
Guillain-Barré Syndrome Warning Added to Shingrix Vaccine in Australia
In February 2024, Australia’s Therapeutic Goods Administration (TGA), the country’s national regulatory authority for drugs and, initiated an investigation into a potential association between GSK plc’s Shingrix shingles vaccine, Guillain-Barré syndrome (GBS), which causes inflammation and damage to the nerves, that may include paralysis.1 The investigation was prompted by two reports of GBS following Shingrix […]
CT Scan Radiation Linked to Cancer, Especially in Children
Computed Tomography (CT) scans use X-rays to provide detailed cross section images of the body’s internal organs, bones and soft tissues for the purpose of diagnosing disease and injuries. They’re commonly used to help detect and treat a wide range of conditions, from bone fractures and cancer tumors to heart disease and blood clots. CT […]
Pfizer Ends Development of Weight-Loss Pill After Liver Injury in Trial Participant
Pfizer, Inc. announced that it is discontinuing development of its experimental daily weight loss pill after a trial participant suffered a liver injury potentially linked to the drug. The company confirmed that the oral GLP-1 drug, danuglipron (PF-06882961), is no longer in development following the incident.1 Pfizer has been studying danuglipron since 2022.2 A Pfizer […]